Videos

‘Majority of Patients’ With Cholangiocarcinoma Still Receive Upfront Standard of Care Despite Recent FDA Drug Approvals

March 8th 2022

Despite several FDA drug approvals over the past few years in the cholangiocarcinoma space, many patients are ineligible for these treatments as a first option, signaling a significant unmet need.

Advocate Emphasizes ‘Investing in Yourself’ to Improve Patient-Physician Communication

March 3rd 2022

As part of its Speaking Out video series, CURE spoke with Throwing Bones founder, Kenny Caps, about improving patient-physician communication throughout myeloma care.

Long-Term Care of Myeloma May Not Be ‘One-Stop-Shop,’ Multidisciplinary Approach Can Help

March 3rd 2022

As part of its Speaking Out video series, CURE spoke with Throwing Bones founder, Kenny Caps, about treating myeloma as a chronic disease and how the multidisciplinary approach to care can assist in challenges, like financial toxicity.

Educated Patient® Webinar: Coping with Metastatic Breast Cancer and Advocating for Others

March 2nd 2022

Hear from our 2021 Metastatic Breast Cancer Heroes™ award winners as they discuss their dedication to the field and how to drive attention and awareness to metastatic disease, how patients can self-advocate and find the right support and resources and advancing diversity and inclusion in metastatic breast cancer.

Patient Encourages Others to ‘Continue Living’ After a Myeloma Diagnosis By Advocating

March 2nd 2022

As part of its Speaking Out video series, CURE spoke with Throwing Bones founder, Kenny Caps, about raising awareness for multiple myeloma, and why sharing one’s story is helpful for others.

Expert Emphasizes Importance of Integrative Care, Well-Being in Long-Term Care of MPNs

February 24th 2022

On behalf of the Canadian MPN Research Foundation, CURE spoke with Dr. Pierre Villeneuve, from the University of Ottawa, about the long-term care of MPNs.

Improving Overall Care of MPNs with Support Groups and Advocacy Research

February 24th 2022

On behalf of the Canadian MPN Research Foundation, CURE spoke with Dr. Pierre Villeneuve, from the University of Ottawa, about MPN resources and support groups available to patients and loved ones.

Taking an Active Voice in MPN Treatment to Improve Communication About Care

February 24th 2022

On behalf of the Canadian MPN Research Foundation, CURE spoke with Dr. Shireen Sirhan, from the Jewish General Hospital-McGIll University, about patients being their own best advocate in their MPN care.

Expert Emphasizes Importance of Finding Specialized Multidisciplinary Team to Treat MPNs

February 24th 2022

On behalf of the Canadian MPN Research Foundation, CURE spoke with Dr. Shireen Sirhan, from the Jewish General Hospital-McGIll University, about finding a care team that specializes in MPNs.

Caring for the Caregiver: Expert Emphasizes Loved Ones of Patients with MPNs Shouldn’t Take This Role on Alone

February 24th 2022

On behalf of the Canadian MPN Research Foundation, CURE spoke with Dr. Pierre Villeneuve, from the University of Ottawa, about the role of caregivers after an MPN diagnosis.

Eating After My Cancer Treatment Was So Painful, It Felt Like I Had Strep Throat for 1 Year

February 15th 2022

After realizing that alcohol and spicy foods were excruciating to consume after treatment, throat cancer survivor Rob Paulsen learned that smoothies were a much healthier — and more soothing — option.

Future Perspectives in Adjuvant Therapy for Early Non-Small Cell Lung Cancer Therapy

February 14th 2022

Two experts explain how early-stage non-small cell lung cancer treatment has changed in recent years, particularly in the adjuvant setting, and offer future perspectives in this space.

Cancer Survivor Encourages Others to Create a Daily Routine to Help Cope with ‘Scanxiety’

February 8th 2022

“Coping for me has been routine-based, and that is making sure I do the things that are in my day that are really foundationally making me feel joyful,” says a survivor of an advanced-stage cancer on how to cope with “scanxiety.”

‘It’s Go Time’: A Patient With Metastatic Breast Cancer Offers Advice on Taking a Step Back, Learning More About a Diagnosis

February 7th 2022

As part of its CURE Speaking Out video series, CURE spoke with Jessica Storm, a patient with metastatic triple-negative breast cancer, about learning of her diagnosis and her advice for others based on her experience.

Knowledge is Power: A Patient With Metastatic Breast Cancer Advocates for Self-Awareness, Not Being Afraid to Ask Questions

February 7th 2022

As part of its CURE Speaking Out video series, CURE spoke with Natalia Green, senior producer and co-host of Our MBC Life, about the importance of patient-physician communication and its impact on treatment decision-making.

‘A Sorority I Never Wanted to Join’: A Patient Helps Others to Find Support for Metastatic Breast Cancer

February 7th 2022

As part of its CURE Speaking Out video series, CURE spoke with Shirley Mertz, president of the Metastatic Breast Cancer Network, about finding support after a metastatic breast cancer diagnosis.

Ongoing Trials in the Adjuvant Setting in Early Non-Small Cell Lung Cancer

February 7th 2022

Dr. Jessica Donington provides an overview of key ongoing clinical trials of systemic adjuvant therapy in early non-small cell lung cancer.

The Role of the Patient in Early Non-Small Cell Lung Cancer Adjuvant Therapy Selection

February 7th 2022

An expert surgeon explains the role patients have in adjuvant therapy selection for early non-small cell lung cancer.

Selecting Appropriate Adjuvant Therapies for Early Non-Small Cell Lung Cancer

January 31st 2022

Dr. Martin Dietrich reviews some factors to consider when selecting an adjuvant therapy for early non-small cell lung cancer.

Talking to Early Non-Small Cell Lung Cancer Patients About Adjuvant Therapy

January 31st 2022

Jessica Donington, MD, MSCR, describes how she discusses adjuvant therapy with patients diagnosed with early non-small cell lung cancer.

Early Non-Small Cell Lung Cancer: The IMpower010 Trial

January 24th 2022

An expert oncologist details the design, outcomes, and clinical implications of the IMpower010 trial.

Early Non-Small Cell Lung Cancer and the ADAURA Trial

January 24th 2022

Dr. Jessica Donington explains how the results of the ADAURA trial changed the treatment algorithm in the adjuvant setting in early non-small cell lung cancer.

‘Make an Impact and Seize the Day’ Says Cancer Survivor Who Launched Kindness Challenge

January 21st 2022

Lorelei Colbert was diagnosed with triple-negative breast cancer at 28 and used her experience to launch the “Chemo to Kindness” challenge that inspired others around the world to do acts of good.

Early Non-Small Cell Lung Cancer: Chemotherapy and Toxicity

January 17th 2022

Martin Dietrich, MD, PhD, describes the toxicity profiles of chemotherapy agents used in the adjuvant setting in early non-small cell lung cancer.

Early Non-Small Cell Lung Cancer and Adjuvant Therapy

January 17th 2022

Two experts detail the use of adjuvant therapy, including chemotherapy, in treating early non-small cell lung cancer.

Know the Risks and Benefits of Robotic Navigational Bronchoscopy for Lung Cancer

January 15th 2022

While robotic navigational bronchoscopy is an exciting advancement in diagnosing and staging lung cancer, the procedure does come with some risks and factors to consider, explained one expert.

From Vaccines to Pills and Clinical Trials: An Overview of Treatments to Protect Patients With Cancer from COVID-19

January 13th 2022

An infectious disease expert explains the new and upcoming treatment modalities that are improving COVID-19 outcomes for patients with cancer and other conditions that compromise the immune system.

‘Shock to the Heart’: A Cancer Survivor Recalls the Emotions of Her First Chemo Treatment

January 12th 2022

After not knowing quite what to expect from her first chemotherapy treatment, colorectal cancer survivor Yla Flores describes the pain she felt in her heart after seeing other patients in worse conditions.

Molecular Testing for Early Non-Small Cell Lung Cancer

January 11th 2022

Dr. Martin Dietrich explains the role of molecular testing in early non-small cell lung cancer.

An Overview of Early Non-Small Cell Lung Cancer

January 11th 2022

Martin Dietrich, MD, PhD, and Jessica Donington, MD, MSCR, provide an overview on early non-small cell lung cancer and the available treatment options.